Article Details

Fierce15 winner Rallybio establishes proof-of-concept in phase 1/2 study for rare fetal bleeding ...

Retrieved on: 2021-07-02 15:45:00

Tags for this article:

Click the tags to see associated articles and topics

Fierce15 winner Rallybio establishes proof-of-concept in phase 1/2 study for rare fetal bleeding .... View article details on hiswai:

Excerpt

... for an antibody treatment aiming to prevent a rare disease that causes a mother's immune system to attack her fetus or newborn child's platelets.

Article found on: www.fiercebiotech.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up